Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation—A Case Report
Abstract
1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- CDC. Toxoplasmosis. 2019. Available online: www.cdc.gov/parasites/toxoplasmosis/disease.html (accessed on 12 February 2021).
- Parlog, A.; Schlüter, D.; Dunay, I.R. Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 2015, 37, 159–170. [Google Scholar] [CrossRef] [PubMed]
- Vidal, J.E. HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease. J. Int. Assoc. Provid. AIDS Care (JIAPAC) 2019, 18, 1–20. [Google Scholar] [CrossRef] [PubMed]
- UpToDate. Toxoplasmosis in Patients with HIV. (n.d.). Available online: https://www.uptodate.com/contents/toxoplasmosis-in-patients-with-hiv (accessed on 12 February 2021).
- Kloska, S.P.; Husstedt, I.W.; Schlegel, P.M.; Anneken, K.; Evers, S.; Fischbach, R.; Heindel, W. Magnetresonanztomografische Befunde des Gehirns bei adulten Patienten mit HIV und AIDS. RöFo Fortschr. Geb. Röntgenstrahlen Bildgeb. Verfahr. 2008, 180, 21–29. [Google Scholar] [CrossRef] [PubMed]
- Katz, I.T.; Ryu, A.E.; Onuegbu, A.G.; Psaros, C.; Weiser, S.D.; Bangsberg, D.R.; Tsai, A.C. Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. J. Int. AIDS Soc. 2013, 16, 18640. [Google Scholar] [CrossRef] [PubMed]
- Odili, V.U.; Obieche, A.O.; Amibor, K.C. Adherence to Antiretroviral Therapy and Its Determinants Among HIV-Infected Patients in Nigeria. J. Pharm. Pract. 2017, 30, 291–295. [Google Scholar] [CrossRef] [PubMed]
- Parczewski, M.; Bociąga-Jasik, M.; Inglot, M.; Mularska, E.; Witak-Jędra, M. Zasady Opieki nad Osobami Zakażonymi HIV; Polskie Towarzystwo Naukowe AIDS: Warszawa, Poland; Szczecin, Poland, 2019. [Google Scholar]
- Rostami, A.; Karanis, P.; Fallahi, S. Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection. Infection 2018, 46, 303–315. [Google Scholar] [CrossRef] [PubMed]
- Karanis, P.; Ongerth, J. LAMP—A powerful and flexible tool for monitoring microbial pathogens. Trends Parasitol. 2009, 25, 498–499. [Google Scholar] [CrossRef] [PubMed]
- Montoya, J.G. Laboratory Diagnosis ofToxoplasma gondiiInfection and Toxoplasmosis. J. Infect. Dis. 2002, 185, S73–S82. [Google Scholar] [CrossRef] [PubMed]
- ClinicalInfo. Toxoplasma Gondii Encephalitis. (n.d.). Available online: https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/toxoplasma-gondii-encephalitis (accessed on 12 February 2021).
- Ueno, H.; Norose, K.; Kamimura, T.; Mihara, K.; Yamasaki, F.; Hikosaka, K.; Amatya, V.J.; Takeshima, Y.; Kurisu, K.; Maruyama, H. Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the “Target Sign”. Intern. Med. 2019, 58, 1157–1162. [Google Scholar] [CrossRef] [PubMed]
- Pittner, Y.; Dufour, J.-F.; David, G.; Boibieux, A.; Peyramond, D. Toxoplasmose médullaire au cours de l’infection à VIH. Méd. Mal. Infect. 2009, 39, 401–405. [Google Scholar] [CrossRef] [PubMed]
- UpToDate. Approach to the Patient with HIV and Central Nervous System Lesions. (n.d.). Available online: https://www.uptodate.com/contents/approach-to-the-patient-with-hiv-and-central-nervous-system-lesions (accessed on 12 February 2021).
- Chiavazza, C.; Pellerino, A.; Ferrio, F.; Cistaro, A.; Soffietti, R.; Rudà, R. Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring. BioMed Res. Int. 2018, 2018, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Grønborg, H.L.; Jespersen, S.; Hønge, B.L.; Jensen-Fangel, S.; Wejse, C. Review of cytomegalovirus coinfection in HIV-infected individuals in Africa. Rev. Med. Virol. 2016, 27, e1907. [Google Scholar] [CrossRef] [PubMed]
- Gómez-Mora, E.; Massanella, M.; García, E.; Giles, D.; Bernadó, M.; Urrea, V.; Carrillo, J.; Ouchi, D.; Puig, J.; Negredo, E.; et al. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. PLoS ONE 2017, 12, e0184433. [Google Scholar] [CrossRef] [PubMed]
- Christensen-Quick, A.; Massanella, M.; Frick, A.; Rawlings, S.A.; Spina, C.; Vargas-Meneses, M.; Schrier, R.; Nakazawa, M.; Anderson, C.; Gianella, S. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy. J. Virol. 2019, 93. [Google Scholar] [CrossRef] [PubMed]
- Kaufmann, G.R.; Perrin, L.; Pantaleo, G.; Opravil, M.; Furrer, H.; Telenti, A.; Hirschel, B.; Ledergerber, B.; Vernazza, P.; Bernasconi, E.; et al. CD4 T-Lymphocyte Recovery in Individuals with Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 YearsThe Swiss HIV Cohort Study. Arch. Intern. Med. 2003, 163, 2187–2195. [Google Scholar] [CrossRef] [PubMed]
- Lederman, M.M.; Calabrese, L.; Funderburg, N.T.; Clagett, B.; Medvik, K.; Bonilla, H.; Gripshover, B.; Salata, R.A.; Taege, A.; Lisgaris, M.; et al. Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells. J. Infect. Dis. 2011, 204, 1217–1226. [Google Scholar] [CrossRef] [PubMed]
- Olsen, C.H.; Mocroft, A.; Kirk, O.; Vella, S.; Blaxhult, A.; Clumeck, N.; Fisher, M.; Katlama, C.; Phillips, A.; Lundgren, J.; et al. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med. 2007, 8, 96–104. [Google Scholar] [CrossRef] [PubMed]
- Günthard, H.F.; Aberg, J.A.; Eron, J.J.; Hoy, J.F.; Telenti, A.; Benson, C.A.; Burger, D.M.; Cahn, P.; Gallant, J.E.; Glesby, M.J.; et al. Antiretroviral Treatment of Adult HIV Infection. JAMA 2014, 312, 410–425. [Google Scholar] [CrossRef]
- Smurzynski, M.; Wu, K.; Benson, C.A.; Bosch, R.J.; Collier, A.C.; Koletar, S.L. Relationship Between CD4+ T-Cell Counts/HIV-1 RNA Plasma Viral Load and AIDS-Defining Events Among Persons Followed in the ACTG Longitudinal Linked Randomized Trials Study. JAIDS J. Acquir. Immune Defic. Syndr. 2010, 55, 117–127. [Google Scholar] [CrossRef]
Date | CD4+ T-Cells [Cells/µL] | Viral Load [Copies/mL] |
---|---|---|
July 2013 | 607 | undetactable |
May 2016 (short, unknown time after therapy cessation) | 329 | 29,342 |
March 2018 (on admission) | 28 | 400,313 |
April 2018 (after 4 weeks of treatment) | 4 | 264 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Piwowarek, M.; Siennicka, K.; Mikuła, T.; Wiercińska-Drapało, A. Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation—A Case Report. Pathogens 2021, 10, 497. https://doi.org/10.3390/pathogens10040497
Piwowarek M, Siennicka K, Mikuła T, Wiercińska-Drapało A. Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation—A Case Report. Pathogens. 2021; 10(4):497. https://doi.org/10.3390/pathogens10040497
Chicago/Turabian StylePiwowarek, Marta, Katarzyna Siennicka, Tomasz Mikuła, and Alicja Wiercińska-Drapało. 2021. "Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation—A Case Report" Pathogens 10, no. 4: 497. https://doi.org/10.3390/pathogens10040497
APA StylePiwowarek, M., Siennicka, K., Mikuła, T., & Wiercińska-Drapało, A. (2021). Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation—A Case Report. Pathogens, 10(4), 497. https://doi.org/10.3390/pathogens10040497